CD82 controls CpG-dependent TLR9 signaling
More about Open Access at the CrickAuthors list
Nida S Khan Daniel P Lukason Marianela Feliu Rebecca A Ward Allison K Lord Jennifer L Reedy Zaida G Ramirez-Ortiz Jenny M Tam Pia V Kasperkovitz Paige E Negoro Tammy D Vyas Shuying Xu Melanie M Brinkmann Mridu Acharaya Katerina Artavanis-Tsakonas Eva-Maria Frickel Christine E Becker Zeina Dagher You-Me Kim Eicke Latz Hidde L Ploegh Michael K Mansour Cindy K Miranti Stuart M Levitz Jatin M VyasAbstract
The tetraspanin CD82 is a potent suppressor of tumor metastasis and regulates several processes including signal transduction, cell adhesion, motility, and aggregation. However, the mechanisms by which CD82 participates in innate immunity are unknown. We report that CD82 is a key regulator of TLR9 trafficking and signaling. TLR9 recognizes unmethylated cytosine-phosphate-guanine (CpG) motifs present in viral, bacterial, and fungal DNA. We demonstrate that TLR9 and CD82 associate in macrophages, which occurs in the endoplasmic reticulum (ER) and post-ER. Moreover, CD82 is essential for TLR9-dependent myddosome formation in response to CpG stimulation. Finally, CD82 modulates TLR9-dependent NF-κB nuclear translocation, which is critical for inflammatory cytokine production. To our knowledge, this is the first time a tetraspanin has been implicated as a key regulator of TLR signaling. Collectively, our study demonstrates that CD82 is a specific regulator of TLR9 signaling, which may be critical in cancer immunotherapy approaches and coordinating the innate immune response to pathogens.-Khan, N. S., Lukason, D. P., Feliu, M., Ward, R. A., Lord, A. K., Reedy, J. L., Ramirez-Ortiz, Z. G., Tam, J. M., Kasperkovitz, P. V., Negoro, P. E., Vyas, T. D., Xu, S., Brinkmann, M. M., Acharaya, M., Artavanis-Tsakonas, K., Frickel, E.-M., Becker, C. E., Dagher, Z., Kim, Y.-M., Latz, E., Ploegh, H. L., Mansour, M. K., Miranti, C. K., Levitz, S. M., Vyas, J. M. CD82 controls CpG-dependent TLR9 signaling.
Journal details
Volume 33
Issue number 11
Pages 12500-12514
Available online
Publication date
Full text links
Publisher website (DOI) 10.1096/fj.201901547R
Europe PubMed Central 31408613
Pubmed 31408613
Keywords
Related topics
Type of publication